董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Fumitoshi Fujiwara | 男 | Independent Director | 60 | 8.01万 | 未持股 | 2026-04-30 |
| Mike Sayama | 男 | Independent Director | 71 | 4.01万 | 1.50 | 2026-04-30 |
| Yoshiyuki Aikawa | 男 | Chairman of the Board and Chief Executive Officer and Director | 55 | 1200.00万 | 8383.95 | 2026-04-30 |
| Ken Edahiro | 男 | Independent Director | 44 | 4.01万 | 未持股 | 2026-04-30 |
| Yuya Yoshida | 男 | Chief Financial Officer and Chief Operating Officer and Director | 47 | 41.61万 | 未持股 | 2026-04-30 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Yoshiyuki Aikawa | 男 | Chairman of the Board and Chief Executive Officer and Director | 55 | 1200.00万 | 8383.95 | 2026-04-30 |
| Miki Yamazaki | 女 | Chief Strategy Officer | 40 | 35.92万 | 未持股 | 2026-04-30 |
| Yuya Yoshida | 男 | Chief Financial Officer and Chief Operating Officer and Director | 47 | 41.61万 | 未持股 | 2026-04-30 |
董事简历
中英对照 | 中文 | 英文- Fumitoshi Fujiwara
-
Fumitoshi Fujiwara自2017年3月起担任我们的首席财务官和董事会董事。藤原先生创立了Eaglestone Capital Management，并自2009年以来担任其首席执行官。在加入Eaglestone之前，Fujiwara先生于2003年创立了AC Capital Inc.，这是一家私募股权公司。在AC Capital任职期间，Fujiwara先生为Tully&8217；s Coffee Japan筹集了200亿日元的投资，并于2002年6月至2009年6月担任AC Capital Inc.的代表董事。在AC Capital之前，Fujiwara先生于2002年创立了Star Capital Partners，Inc.，并担任其首席执行官直到2001年10月。加入Star Capital Partners之前，Fujiwara从2000年10月到2001年10月担任Spiralstar Japan，Inc.执行合伙人和董事。任职Spiralstar Japan公司之前，Fujiwara先生曾创立其他公司，也曾担任Shuwa Corporation和Koei Tecmo Holdings Co.，Ltd.（前身为Koei Co.Ltd.）的众多职务，包括财务、房地产和投资者关系部门的职务。藤原先生于2003年至2018年担任日本周转专业人员协会的董事，并于2000年10月至2009年3月担任尽职调查Meister Inc.的缺席董事。Fujiwara先生在明治学院大学（Meiji Gakuin University）获得法学文学学士学位。
Fumitoshi Fujiwara has served as a director of the Company since September 17, 2024. Mr. Fujiwara has served as an executive officer to Medirom Healthcare Technologies Inc. (NASDAQ: MRM) since March 2017. In addition, since 2023, he has served as managing partner and chief executive officer of Linden Capital Partners LLC. Furthermore, since November 2009, Mr. Fujiwara has served as a director, managing partner and chief executive officer to Eaglestone Capital Management Inc. From 2001 to 2009, he served as a director, managing partner and chief executive officer of AC Capital Inc. From 2000 to 2001, Mr. Fujiwara served as a director, managing partner and chief investment officer to Spiral & Star Co., Ltd. From 1993 to 2000, he served as the chief executive officer and chief financial officer to KOEI Tecmo Holdings Co., Ltd. From 1989 to 1993, Mr. Fujiwara served as a manager to Shuwa Corporation. He graduated from Meiji Gakuin University, Faculty of Law in 1989. Mr. Fujiwara does not hold, and has not held, any directorships in any reporting companies. - Fumitoshi Fujiwara自2017年3月起担任我们的首席财务官和董事会董事。藤原先生创立了Eaglestone Capital Management，并自2009年以来担任其首席执行官。在加入Eaglestone之前，Fujiwara先生于2003年创立了AC Capital Inc.，这是一家私募股权公司。在AC Capital任职期间，Fujiwara先生为Tully&8217；s Coffee Japan筹集了200亿日元的投资，并于2002年6月至2009年6月担任AC Capital Inc.的代表董事。在AC Capital之前，Fujiwara先生于2002年创立了Star Capital Partners，Inc.，并担任其首席执行官直到2001年10月。加入Star Capital Partners之前，Fujiwara从2000年10月到2001年10月担任Spiralstar Japan，Inc.执行合伙人和董事。任职Spiralstar Japan公司之前，Fujiwara先生曾创立其他公司，也曾担任Shuwa Corporation和Koei Tecmo Holdings Co.，Ltd.（前身为Koei Co.Ltd.）的众多职务，包括财务、房地产和投资者关系部门的职务。藤原先生于2003年至2018年担任日本周转专业人员协会的董事，并于2000年10月至2009年3月担任尽职调查Meister Inc.的缺席董事。Fujiwara先生在明治学院大学（Meiji Gakuin University）获得法学文学学士学位。
- Fumitoshi Fujiwara has served as a director of the Company since September 17, 2024. Mr. Fujiwara has served as an executive officer to Medirom Healthcare Technologies Inc. (NASDAQ: MRM) since March 2017. In addition, since 2023, he has served as managing partner and chief executive officer of Linden Capital Partners LLC. Furthermore, since November 2009, Mr. Fujiwara has served as a director, managing partner and chief executive officer to Eaglestone Capital Management Inc. From 2001 to 2009, he served as a director, managing partner and chief executive officer of AC Capital Inc. From 2000 to 2001, Mr. Fujiwara served as a director, managing partner and chief investment officer to Spiral & Star Co., Ltd. From 1993 to 2000, he served as the chief executive officer and chief financial officer to KOEI Tecmo Holdings Co., Ltd. From 1989 to 1993, Mr. Fujiwara served as a manager to Shuwa Corporation. He graduated from Meiji Gakuin University, Faculty of Law in 1989. Mr. Fujiwara does not hold, and has not held, any directorships in any reporting companies.
- Mike Sayama
-
Mike Sayama担任独立董事。自Community First于2016年7月至2021年1月成立以来，Sayama博士曾担任该公司的执行董事。作为创始执行董事，他负责运营、制定东夏威夷负责任的卫生社区战略计划、社区关系和筹款。从2021年1月到2021年6月，他担任战略总监，以促进向新管理团队的过渡。从2013年10月到2018年12月，Sayama博士担任副总裁0 Health的副总裁，并担任Learning Health Homes的总监，在该项目中，他负责管理东夏威夷独立医师协会并实施集成健康计划、医院和医师数据的数据平台。Sayama博士还促进了EHI的重组和战略方向的发展。Community First是一个501c 3的非营利组织，是东夏威夷医疗保健利益相关者的中立论坛，它源于学习健康之家倡议，1997年8月至2013年10月，Sayama博士担任夏威夷医疗服务协会的副总裁，首先是健康福利管理，然后是客户关系。在第一个职位上，他简化了预授权和上诉流程，包括在不增加住院利用率的情况下取消了住院入院的预授权。在他的第二个职位上，他在希洛建立了呼叫中心，稳定了呼叫中心的工作队伍并提高了客户服务的及时性和准确性。2001年4月至2005年4月，Sayama博士担任城市银行董事会董事，并于2005年4月至2009年4月担任Central Pacific Bank和中央太平洋银行公司的董事。他目前在Pono Capital公司董事会任职。在教育方面：1975年5月，他获得耶鲁大学心理学文学学士学位，1979年8月，他获得密歇根大学临床心理学文学硕士学位。1982年8月，Sayama博士获得了博士学位。密歇根大学临床心理学学位。他是几本关于心理治疗和禅佛的书的作者。他的社区服务包括曾担任Bay Clinic Board（东夏威夷联邦合格的健康中心）的董事，目前担任国际禅道场Chozen-Ji的住持。
Mike Sayama serves as an independent director of the Company since March 11, 2022 (including for time prior to the Business Combination). Dr. Sayama was formerly the Executive Director of Community First since it was established in July 2016 until January 2021. As the founding executive director, he was responsible for operations, developing a strategic plan for an accountable health community in East Hawaii, community relations, and fund raising. From January 2021 to June 2021 he served as the Director of Strategy to facilitate the transition to a new management team. From October 2013 to December 2018, Dr. Sayama served as a Vice President at Pono Health and was Director of Learning Health Homes, a project where he was responsible for managing the East Hawaii Independent Physicians Association and implementing a data platform integrating health plan, hospital, and physician data. Dr. Sayama also facilitated the reorganization of EHI and development of its strategic direction. Community First, a 501(c)(3) non profit, which serves as a neutral forum for healthcare stakeholders in East Hawaii, grew out of the Learning Health Homes Initiative. From August 1997 to October 2013, Dr. Sayama served as a Vice President of the Hawaii Medical Service Association, first in Health Benefits Management and then in Customer Relations. In the first position, he streamlined preauthorization and appeal processes, including the elimination of preauthorization for inpatient admissions without increase in inpatient utilization. In his second position he established call centers in Hilo which stabilized the call center work force and improved the timeliness and accuracy of customer service. From April 2001 to April 2005, Dr. Sayama was a director on the board of City Bank, and from April 2005 to April 2009, was a director on the boards of Central Pacific Bank and Central Pacific Financial Corporation. Regarding education: In May 1975, he received his Bachelor of Arts degree in Psychology from Yale University, and in August 1979, his Master of Arts degree in Clinical Psychology from University of Michigan. In August 1982, Dr. Sayama received his Ph.D. degree in Clinical Psychology from University of Michigan. He is the author of several books on psychotherapy and Zen Buddhism. His community service includes having been a Director on the Bay Clinic Board (the Federally Qualified Health Center in East Hawaii) and currently serving as the Abbot of Chozen ji, International Zen Dojo. Mr. Sayama has broad knowledge of the healthcare technology industry, as well as prior experience serving as a founding executive director, which makes him a valuable member of Sbc Medical Group Holdings Incorporated's board of directors. - Mike Sayama担任独立董事。自Community First于2016年7月至2021年1月成立以来，Sayama博士曾担任该公司的执行董事。作为创始执行董事，他负责运营、制定东夏威夷负责任的卫生社区战略计划、社区关系和筹款。从2021年1月到2021年6月，他担任战略总监，以促进向新管理团队的过渡。从2013年10月到2018年12月，Sayama博士担任副总裁0 Health的副总裁，并担任Learning Health Homes的总监，在该项目中，他负责管理东夏威夷独立医师协会并实施集成健康计划、医院和医师数据的数据平台。Sayama博士还促进了EHI的重组和战略方向的发展。Community First是一个501c 3的非营利组织，是东夏威夷医疗保健利益相关者的中立论坛，它源于学习健康之家倡议，1997年8月至2013年10月，Sayama博士担任夏威夷医疗服务协会的副总裁，首先是健康福利管理，然后是客户关系。在第一个职位上，他简化了预授权和上诉流程，包括在不增加住院利用率的情况下取消了住院入院的预授权。在他的第二个职位上，他在希洛建立了呼叫中心，稳定了呼叫中心的工作队伍并提高了客户服务的及时性和准确性。2001年4月至2005年4月，Sayama博士担任城市银行董事会董事，并于2005年4月至2009年4月担任Central Pacific Bank和中央太平洋银行公司的董事。他目前在Pono Capital公司董事会任职。在教育方面：1975年5月，他获得耶鲁大学心理学文学学士学位，1979年8月，他获得密歇根大学临床心理学文学硕士学位。1982年8月，Sayama博士获得了博士学位。密歇根大学临床心理学学位。他是几本关于心理治疗和禅佛的书的作者。他的社区服务包括曾担任Bay Clinic Board（东夏威夷联邦合格的健康中心）的董事，目前担任国际禅道场Chozen-Ji的住持。
- Mike Sayama serves as an independent director of the Company since March 11, 2022 (including for time prior to the Business Combination). Dr. Sayama was formerly the Executive Director of Community First since it was established in July 2016 until January 2021. As the founding executive director, he was responsible for operations, developing a strategic plan for an accountable health community in East Hawaii, community relations, and fund raising. From January 2021 to June 2021 he served as the Director of Strategy to facilitate the transition to a new management team. From October 2013 to December 2018, Dr. Sayama served as a Vice President at Pono Health and was Director of Learning Health Homes, a project where he was responsible for managing the East Hawaii Independent Physicians Association and implementing a data platform integrating health plan, hospital, and physician data. Dr. Sayama also facilitated the reorganization of EHI and development of its strategic direction. Community First, a 501(c)(3) non profit, which serves as a neutral forum for healthcare stakeholders in East Hawaii, grew out of the Learning Health Homes Initiative. From August 1997 to October 2013, Dr. Sayama served as a Vice President of the Hawaii Medical Service Association, first in Health Benefits Management and then in Customer Relations. In the first position, he streamlined preauthorization and appeal processes, including the elimination of preauthorization for inpatient admissions without increase in inpatient utilization. In his second position he established call centers in Hilo which stabilized the call center work force and improved the timeliness and accuracy of customer service. From April 2001 to April 2005, Dr. Sayama was a director on the board of City Bank, and from April 2005 to April 2009, was a director on the boards of Central Pacific Bank and Central Pacific Financial Corporation. Regarding education: In May 1975, he received his Bachelor of Arts degree in Psychology from Yale University, and in August 1979, his Master of Arts degree in Clinical Psychology from University of Michigan. In August 1982, Dr. Sayama received his Ph.D. degree in Clinical Psychology from University of Michigan. He is the author of several books on psychotherapy and Zen Buddhism. His community service includes having been a Director on the Bay Clinic Board (the Federally Qualified Health Center in East Hawaii) and currently serving as the Abbot of Chozen ji, International Zen Dojo. Mr. Sayama has broad knowledge of the healthcare technology industry, as well as prior experience serving as a founding executive director, which makes him a valuable member of Sbc Medical Group Holdings Incorporated's board of directors.
- Yoshiyuki Aikawa
-
相川佳幸是日本公民。
Yoshiyuki Aikawa has served as Sbc Medical Group Holdings Incorporated's Chief Executive Officer and Chairman of Sbc Medical Group Holdings Incorporated's Board of Directors since September 17, 2024, and in the same positions with SBC Medical Group, Inc. since January 20, 2023. Additionally, since September 2017, Dr. Aikawa has been the Chief Executive Officer of SBC Medical Group Co., Ltd. (formerly known as Aikawa Medical Group Co., Ltd.), a Japanese company that provides management services to clinics. Dr. Aikawa, stepped down from his position as Chief Executive Officer and Representative of SBC Medical Group Co., Ltd. on September 1, 2024, and remains as a director of SBC Medical Group Co., Ltd. In March 2000, Dr. Aikawa opened Shonan Beauty Clinic in Fujisawa, Japan, as a private clinic. Subsequently, he expanded his operations to include multiple cosmetic surgery clinics, transforming the clinic into a corporation. From January 2016 to December 2019, Dr. Aikawa served as the chairman of the MC. From 2014 to 2015, Dr. Aikawa was the president and a director of the Japanese Society of Aesthetic Plastic Surgery. Additionally, from 2008, he was associated with Harvard Medical School, PGA. Dr. Aikawa is also a member of the Japanese Society of Aesthetic Plastic Surgery, Japan Laser Therapy Association, Japan Liposuction Society, Chemical Peeling Society, Japanese Society of Anesthesiologists, and PostGraduate Assembly of Anesthesiology at Harvard Medical School. Dr. Aikawa holds a medical license from Nihon University Medical School, where he graduated in 1997. Dr. Aikawa does not hold, and has not previously held, any directorships in any reporting companies. - 相川佳幸是日本公民。
- Yoshiyuki Aikawa has served as Sbc Medical Group Holdings Incorporated's Chief Executive Officer and Chairman of Sbc Medical Group Holdings Incorporated's Board of Directors since September 17, 2024, and in the same positions with SBC Medical Group, Inc. since January 20, 2023. Additionally, since September 2017, Dr. Aikawa has been the Chief Executive Officer of SBC Medical Group Co., Ltd. (formerly known as Aikawa Medical Group Co., Ltd.), a Japanese company that provides management services to clinics. Dr. Aikawa, stepped down from his position as Chief Executive Officer and Representative of SBC Medical Group Co., Ltd. on September 1, 2024, and remains as a director of SBC Medical Group Co., Ltd. In March 2000, Dr. Aikawa opened Shonan Beauty Clinic in Fujisawa, Japan, as a private clinic. Subsequently, he expanded his operations to include multiple cosmetic surgery clinics, transforming the clinic into a corporation. From January 2016 to December 2019, Dr. Aikawa served as the chairman of the MC. From 2014 to 2015, Dr. Aikawa was the president and a director of the Japanese Society of Aesthetic Plastic Surgery. Additionally, from 2008, he was associated with Harvard Medical School, PGA. Dr. Aikawa is also a member of the Japanese Society of Aesthetic Plastic Surgery, Japan Laser Therapy Association, Japan Liposuction Society, Chemical Peeling Society, Japanese Society of Anesthesiologists, and PostGraduate Assembly of Anesthesiology at Harvard Medical School. Dr. Aikawa holds a medical license from Nihon University Medical School, where he graduated in 1997. Dr. Aikawa does not hold, and has not previously held, any directorships in any reporting companies.
- Ken Edahiro
-
Ken Edahiro自2024年9月17日起担任公司董事。Edahiro先生自2023年11月起担任云服务提供商BizReach的首席战略和营销官，此外，自2025年2月起担任BizReach业务部门总经理。2014年1月至2019年5月，担任互动娱乐龙头企业King总经理。从2012年8月到2013年12月，Edahiro先生担任电脑游戏提供商gloops的全球战略和营销主管。2004年4月至2012年7月，他在广告服务提供商电通担任首席客户主管。2004年，枝弘先生获得了一桥大学的学位。
Ken Edahiro has served as a director of the Company since September 17, 2024. Mr. Edahiro has served as the Chief Strategy and Marketing Officer of BizReach, a Cloud service provider since November 2023, and has, additionally, served as General Manager of BizReach Business Division since February 2025. From January 2014 through May 2019, he served as the General Manager of King, a leading interactive entertainment company. From August 2012 through December 2013, Mr. Edahiro served as the head of global strategy and marketing of gloops, a provider of computer games. From April 2004 through July 2012, he served as a Chief Account Executive at Dentsu, a provider of advertising services. In 2004, Mr. Edahiro received a degree from Hitotsubashi University. - Ken Edahiro自2024年9月17日起担任公司董事。Edahiro先生自2023年11月起担任云服务提供商BizReach的首席战略和营销官，此外，自2025年2月起担任BizReach业务部门总经理。2014年1月至2019年5月，担任互动娱乐龙头企业King总经理。从2012年8月到2013年12月，Edahiro先生担任电脑游戏提供商gloops的全球战略和营销主管。2004年4月至2012年7月，他在广告服务提供商电通担任首席客户主管。2004年，枝弘先生获得了一桥大学的学位。
- Ken Edahiro has served as a director of the Company since September 17, 2024. Mr. Edahiro has served as the Chief Strategy and Marketing Officer of BizReach, a Cloud service provider since November 2023, and has, additionally, served as General Manager of BizReach Business Division since February 2025. From January 2014 through May 2019, he served as the General Manager of King, a leading interactive entertainment company. From August 2012 through December 2013, Mr. Edahiro served as the head of global strategy and marketing of gloops, a provider of computer games. From April 2004 through July 2012, he served as a Chief Account Executive at Dentsu, a provider of advertising services. In 2004, Mr. Edahiro received a degree from Hitotsubashi University.
- Yuya Yoshida
-
吉田雄也还自2023年7月1日起担任SBC医疗集团有限公司（日本）执行副总裁兼首席财务官。2016年1月至2023年6月，吉田先生在乐天集团有限公司从事企业发展工作（2018年担任企业发展全球主管和董事）。2003年至2016年，吉田先生在三菱日联金融集团从事证券、主要并购和投资银行业务。吉田先生在电子商务、物流、结算、金融、并购和剥离交易方面拥有广泛的知识。吉田先生于2003年毕业于庆应义塾大学，获得法学硕士学位。吉田先生还于2014年毕业于加州大学洛杉矶分校安德森商学院，获得工商管理硕士学位。
Yuya Yoshida has served as Sbc Medical Group Holdings Incorporated's Chief Operating Officer and member of Sbc Medical Group Holdings Incorporated's Board of Directors since September 17, 2024, and in the same positions with SBC Medical Group, Inc. since September 29, 2023, and was appointed as Sbc Medical Group Holdings Incorporated's Chief Financial Officer effective April 1, 2025. Mr. Yoshida has also served as the Executive Vice President and the Chief Financial Officer of SBC Medical Group Co., Ltd. (Japan) since July 1, 2023. From January 2016 to June 2023, Mr. Yoshida worked in Corporate Development (Global Head and Director of Corporate Development in 2018) at Rakuten Group Co., Ltd. From 2003 to 2016, Mr. Yoshida worked in securities, principal M&A, and investment banking at Mitsubishi UFJ Financial Group. Mr. Yoshida has extensive knowledge in E Commerce, logistics, settlement, finance, mergers and acquisitions and divestiture transactions. Mr. Yoshida graduated with a Master of Law degree from Keio University in 2003. Mr. Yoshida also graduated with a Master of Business Administration degree from UCLA Anderson Business School in 2014. Mr. Yoshida does not hold, and has not previously held, any directorships in any reporting companies. - 吉田雄也还自2023年7月1日起担任SBC医疗集团有限公司（日本）执行副总裁兼首席财务官。2016年1月至2023年6月，吉田先生在乐天集团有限公司从事企业发展工作（2018年担任企业发展全球主管和董事）。2003年至2016年，吉田先生在三菱日联金融集团从事证券、主要并购和投资银行业务。吉田先生在电子商务、物流、结算、金融、并购和剥离交易方面拥有广泛的知识。吉田先生于2003年毕业于庆应义塾大学，获得法学硕士学位。吉田先生还于2014年毕业于加州大学洛杉矶分校安德森商学院，获得工商管理硕士学位。
- Yuya Yoshida has served as Sbc Medical Group Holdings Incorporated's Chief Operating Officer and member of Sbc Medical Group Holdings Incorporated's Board of Directors since September 17, 2024, and in the same positions with SBC Medical Group, Inc. since September 29, 2023, and was appointed as Sbc Medical Group Holdings Incorporated's Chief Financial Officer effective April 1, 2025. Mr. Yoshida has also served as the Executive Vice President and the Chief Financial Officer of SBC Medical Group Co., Ltd. (Japan) since July 1, 2023. From January 2016 to June 2023, Mr. Yoshida worked in Corporate Development (Global Head and Director of Corporate Development in 2018) at Rakuten Group Co., Ltd. From 2003 to 2016, Mr. Yoshida worked in securities, principal M&A, and investment banking at Mitsubishi UFJ Financial Group. Mr. Yoshida has extensive knowledge in E Commerce, logistics, settlement, finance, mergers and acquisitions and divestiture transactions. Mr. Yoshida graduated with a Master of Law degree from Keio University in 2003. Mr. Yoshida also graduated with a Master of Business Administration degree from UCLA Anderson Business School in 2014. Mr. Yoshida does not hold, and has not previously held, any directorships in any reporting companies.
高管简历
中英对照 | 中文 | 英文- Yoshiyuki Aikawa
相川佳幸是日本公民。
Yoshiyuki Aikawa has served as Sbc Medical Group Holdings Incorporated's Chief Executive Officer and Chairman of Sbc Medical Group Holdings Incorporated's Board of Directors since September 17, 2024, and in the same positions with SBC Medical Group, Inc. since January 20, 2023. Additionally, since September 2017, Dr. Aikawa has been the Chief Executive Officer of SBC Medical Group Co., Ltd. (formerly known as Aikawa Medical Group Co., Ltd.), a Japanese company that provides management services to clinics. Dr. Aikawa, stepped down from his position as Chief Executive Officer and Representative of SBC Medical Group Co., Ltd. on September 1, 2024, and remains as a director of SBC Medical Group Co., Ltd. In March 2000, Dr. Aikawa opened Shonan Beauty Clinic in Fujisawa, Japan, as a private clinic. Subsequently, he expanded his operations to include multiple cosmetic surgery clinics, transforming the clinic into a corporation. From January 2016 to December 2019, Dr. Aikawa served as the chairman of the MC. From 2014 to 2015, Dr. Aikawa was the president and a director of the Japanese Society of Aesthetic Plastic Surgery. Additionally, from 2008, he was associated with Harvard Medical School, PGA. Dr. Aikawa is also a member of the Japanese Society of Aesthetic Plastic Surgery, Japan Laser Therapy Association, Japan Liposuction Society, Chemical Peeling Society, Japanese Society of Anesthesiologists, and PostGraduate Assembly of Anesthesiology at Harvard Medical School. Dr. Aikawa holds a medical license from Nihon University Medical School, where he graduated in 1997. Dr. Aikawa does not hold, and has not previously held, any directorships in any reporting companies.- 相川佳幸是日本公民。
- Yoshiyuki Aikawa has served as Sbc Medical Group Holdings Incorporated's Chief Executive Officer and Chairman of Sbc Medical Group Holdings Incorporated's Board of Directors since September 17, 2024, and in the same positions with SBC Medical Group, Inc. since January 20, 2023. Additionally, since September 2017, Dr. Aikawa has been the Chief Executive Officer of SBC Medical Group Co., Ltd. (formerly known as Aikawa Medical Group Co., Ltd.), a Japanese company that provides management services to clinics. Dr. Aikawa, stepped down from his position as Chief Executive Officer and Representative of SBC Medical Group Co., Ltd. on September 1, 2024, and remains as a director of SBC Medical Group Co., Ltd. In March 2000, Dr. Aikawa opened Shonan Beauty Clinic in Fujisawa, Japan, as a private clinic. Subsequently, he expanded his operations to include multiple cosmetic surgery clinics, transforming the clinic into a corporation. From January 2016 to December 2019, Dr. Aikawa served as the chairman of the MC. From 2014 to 2015, Dr. Aikawa was the president and a director of the Japanese Society of Aesthetic Plastic Surgery. Additionally, from 2008, he was associated with Harvard Medical School, PGA. Dr. Aikawa is also a member of the Japanese Society of Aesthetic Plastic Surgery, Japan Laser Therapy Association, Japan Liposuction Society, Chemical Peeling Society, Japanese Society of Anesthesiologists, and PostGraduate Assembly of Anesthesiology at Harvard Medical School. Dr. Aikawa holds a medical license from Nihon University Medical School, where he graduated in 1997. Dr. Aikawa does not hold, and has not previously held, any directorships in any reporting companies.
- Miki Yamazaki
山崎美纪在高盛日本投资银行部门工作了16年（2008-2024年）。从2016年起，她担任咨询集团副总裁，专门从事并购和资本交易，包括跨境收购、IPO和反维权咨询服务。此外，她自2026年2月起担任AI-Med Inc.总裁兼代表董事。2008年毕业于庆应义塾大学，获学士学位。
Miki Yamazaki has served as Sbc Medical Group Holdings Incorporated's Chief Strategy Officer since April 10, 2025. Previously, she spent 16 years at Goldman Sachs Japan (2008 2024) within their Investment Banking Division. From 2016 onward, she served as Vice President of the Advisory Group, specializing in M&A and capital transactions, including cross border acquisitions, IPOs, and anti activist advisory services. Additionally, she serves as President and Representative Director of Ai Med Inc. since February 2026. She graduated from Keio University with a Bachelor's degree in 2008.- 山崎美纪在高盛日本投资银行部门工作了16年（2008-2024年）。从2016年起，她担任咨询集团副总裁，专门从事并购和资本交易，包括跨境收购、IPO和反维权咨询服务。此外，她自2026年2月起担任AI-Med Inc.总裁兼代表董事。2008年毕业于庆应义塾大学，获学士学位。
- Miki Yamazaki has served as Sbc Medical Group Holdings Incorporated's Chief Strategy Officer since April 10, 2025. Previously, she spent 16 years at Goldman Sachs Japan (2008 2024) within their Investment Banking Division. From 2016 onward, she served as Vice President of the Advisory Group, specializing in M&A and capital transactions, including cross border acquisitions, IPOs, and anti activist advisory services. Additionally, she serves as President and Representative Director of Ai Med Inc. since February 2026. She graduated from Keio University with a Bachelor's degree in 2008.
- Yuya Yoshida
吉田雄也还自2023年7月1日起担任SBC医疗集团有限公司（日本）执行副总裁兼首席财务官。2016年1月至2023年6月，吉田先生在乐天集团有限公司从事企业发展工作（2018年担任企业发展全球主管和董事）。2003年至2016年，吉田先生在三菱日联金融集团从事证券、主要并购和投资银行业务。吉田先生在电子商务、物流、结算、金融、并购和剥离交易方面拥有广泛的知识。吉田先生于2003年毕业于庆应义塾大学，获得法学硕士学位。吉田先生还于2014年毕业于加州大学洛杉矶分校安德森商学院，获得工商管理硕士学位。
Yuya Yoshida has served as Sbc Medical Group Holdings Incorporated's Chief Operating Officer and member of Sbc Medical Group Holdings Incorporated's Board of Directors since September 17, 2024, and in the same positions with SBC Medical Group, Inc. since September 29, 2023, and was appointed as Sbc Medical Group Holdings Incorporated's Chief Financial Officer effective April 1, 2025. Mr. Yoshida has also served as the Executive Vice President and the Chief Financial Officer of SBC Medical Group Co., Ltd. (Japan) since July 1, 2023. From January 2016 to June 2023, Mr. Yoshida worked in Corporate Development (Global Head and Director of Corporate Development in 2018) at Rakuten Group Co., Ltd. From 2003 to 2016, Mr. Yoshida worked in securities, principal M&A, and investment banking at Mitsubishi UFJ Financial Group. Mr. Yoshida has extensive knowledge in E Commerce, logistics, settlement, finance, mergers and acquisitions and divestiture transactions. Mr. Yoshida graduated with a Master of Law degree from Keio University in 2003. Mr. Yoshida also graduated with a Master of Business Administration degree from UCLA Anderson Business School in 2014. Mr. Yoshida does not hold, and has not previously held, any directorships in any reporting companies.- 吉田雄也还自2023年7月1日起担任SBC医疗集团有限公司（日本）执行副总裁兼首席财务官。2016年1月至2023年6月，吉田先生在乐天集团有限公司从事企业发展工作（2018年担任企业发展全球主管和董事）。2003年至2016年，吉田先生在三菱日联金融集团从事证券、主要并购和投资银行业务。吉田先生在电子商务、物流、结算、金融、并购和剥离交易方面拥有广泛的知识。吉田先生于2003年毕业于庆应义塾大学，获得法学硕士学位。吉田先生还于2014年毕业于加州大学洛杉矶分校安德森商学院，获得工商管理硕士学位。
- Yuya Yoshida has served as Sbc Medical Group Holdings Incorporated's Chief Operating Officer and member of Sbc Medical Group Holdings Incorporated's Board of Directors since September 17, 2024, and in the same positions with SBC Medical Group, Inc. since September 29, 2023, and was appointed as Sbc Medical Group Holdings Incorporated's Chief Financial Officer effective April 1, 2025. Mr. Yoshida has also served as the Executive Vice President and the Chief Financial Officer of SBC Medical Group Co., Ltd. (Japan) since July 1, 2023. From January 2016 to June 2023, Mr. Yoshida worked in Corporate Development (Global Head and Director of Corporate Development in 2018) at Rakuten Group Co., Ltd. From 2003 to 2016, Mr. Yoshida worked in securities, principal M&A, and investment banking at Mitsubishi UFJ Financial Group. Mr. Yoshida has extensive knowledge in E Commerce, logistics, settlement, finance, mergers and acquisitions and divestiture transactions. Mr. Yoshida graduated with a Master of Law degree from Keio University in 2003. Mr. Yoshida also graduated with a Master of Business Administration degree from UCLA Anderson Business School in 2014. Mr. Yoshida does not hold, and has not previously held, any directorships in any reporting companies.